Where the future works: the Novartis Campus
We’re proud to share that Switzerland Innovation Park Basel Area recently featured Bottneuro AG in an in-depth interview, highlighting our mission to help people with neurocognitive disorders act, not just cope.
Operating from the Novartis Campus, Bottneuro is part of a thriving ecosystem where academia, startups, and pharmaceutical leaders converge. Our location at the coworking space on campus, managed by Switzerland Innovation Park Basel Area, has provided us with a unique environment to innovate faster, collaborate smarter, and prepare for our upcoming Phase 2 clinical trial.
Where Ideas Meet Execution
The Switzerland Innovation Park Basel Area fosters an open, collaborative culture that supports companies like Bottneuro through every stage of growth. From professional meeting spaces and community events to an environment designed for idea exchange, it’s a place where innovation thrives.
"The Basel life sciences cluster is unlike anywhere else. We’re not just close to the University of Basel and Novartis; we’re part of a community that thrives on collaboration and shared knowledge. The mix of established players and innovative startups creates an energy that is crucial to our growth." - Dr. Thomas Hefti, CEO of Bottneuro
With a Phase 2 clinical trial on the horizon, Bottneuro continues to advance its mission of improving the lives of people with neurocognitive disorders. The support and collaborative spirit of the Switzerland Innovation Park Basel Area play a vital role in our journey from research to real-world impact.
We extend our thanks to the Innovation Park team for featuring our story and for fostering an environment where startups like Bottneuro can thrive.